top of page

Mirador Therapeutics launched with a $400M+ fundraising round today for precision medicine in the I&I space

Founder Mark McKenna describes the unmet need that exists in the I&I space and how Mirador will leverage big data analysis to guide its asset discovery process.



Comments


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page